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Background: Understanding, modelling and influencing the transition between different states of cells, be it
reprogramming of somatic cells to pluripotency or trans-differentiation between cells, is a hot topic in current
biomedical and cell-biological research. Nevertheless, the large body of published knowledge in this area is
underused, as most results are only represented in natural language, impeding their finding, comparison,
aggregation, and usage. Scientific understanding of the complex molecular mechanisms underlying cell transitions
could be improved by making essential pieces of knowledge available in a formal (and thus computable) manner.
Results: We describe the outline of two ontologies for cell phenotypes and for cellular mechanisms which together
enable the representation of data curated from the literature or obtained by bioinformatics analyses and thus for
building a knowledge base on mechanisms involved in cellular reprogramming. In particular, we discuss how
comprehensive ontologies of cell phenotypes and of changes in mechanisms can be designed using the entity-quality
(EQ) model.
Conclusions: We show that the principles for building cellular ontologies published in this work allow deeper insights
into the relations between the continuants (cell phenotypes) and the occurrents (cell mechanism changes) involved in
cellular reprogramming, although implementation remains for future work. Further, our design principles lead to
ontologies that allow the meaningful application of similarity searches in the spaces of cell phenotypes and of
mechanisms, and, especially, of changes of mechanisms during cellular transitions.Background
The (artificial) induction of cell transitions has recently
attracted a lot of attention. A cell phenotype (or cell
type) can be defined by the cell’s repertoire of molecules
and structural components at a certain time, together
with the specific morphology and function they bring
with them. A cell transition is a change in a cell that re-
sults in a new phenotype. For example, the phenotype of
epithelial cells is distinct from the phenotype of fibro-
blasts. Programming of cells is the induction of a cell
phenotype transition, e.g. from fibroblast to epithelial
cell. Reprogramming is the artificially induced transition
of a cell to a cell phenotype, which it (or its predecessor)
had in the past. Potency can be defined as the dispos-
ition of a cell to transition into another cell phenotype;
pluripotency is the ability of a cell to transition naturally
into any of the cell phenotypes of an organism (where a
transition is natural if it is not triggered by a technical* Correspondence: fuellen@uni-rostock.de
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reproduction in any medium, provided the orintervention). Since Takahashi and Yamanaka described
cell reprogramming of fibroblasts back to pluripotency
(also known as generation of iPS, induced pluripotent
stem cells) [1], hundreds of papers have dissected the re-
programming process and the cellular disposition of
pluripotency at an ever-increasing resolution, reviewed
in, e.g., [2] and [3]. This corpus is currently underused
as there is no formal representation of the reported
findings.
Several ontologies already exist in the domain of cell
biology, such as the well-known Gene Ontology (GO)
[4] and the cell type ontology (CL; cf. [5,6]). Bard et al.
[5] proposed formal definitions for CL classes, referring
to properties of cells such as expressed proteins, acti-
vated biological processes, or phenotypic characteristics.
Further cell-related knowledge projects include the Vir-
tual Physiological Human project (http://www.vph-noe.eu/)
that attempts to provide interoperability between differ-
ent databases and tools related to human physiology and
gene expression; the associated software Phenomeblast
(code.google.com/p/phenomeblast) is an ontology-based
tool for aligning and comparing phenotypes across species.Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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phenomena of organisms focus on anatomical features and
only rarely address the cell level (cf. [7-10] and [11]). What
is missing is a comprehensive tool to represent and to
compare cellular phenotypes and their dynamics.
Results and discussion
Cell phenotypes and cell mechanisms
We distinguish between two types of processes going on
in a cell: microscale mechanisms and macroscale changes
thereof. Microscale mechanisms are the interactions be-
tween molecules going on in a cell at a certain time,
while a macroscale change is the transition from one set
of microscale mechanisms going on at one point of time
to another such set at a later time. In order to transfer
ontology-based annotation and search strategies from
phenotypes at the anatomical level [12] to the domain
of cell phenotypes and mechanism changes, we need to
be able to formally describe both (a) cell phenotypes
and (b) mechanism changes. Phenotypes are usually de-
scribed by means of the entity-quality syntax (EQ) using
the Phenotypic Quality Ontology PATO for anatomic
phenotypes [13,14]. To apply the EQ syntax to the cell
level, we outlined two ontologies, an ontology of cell
parts (Figure 1) and an ontology of microscale mechanismsFigure 1 Outline of an ontology of cell parts and its use to describe c
phenotypes, here for epithelial cells, mesenchymal cells and embryonic ste
on the left hand side) and PATO-analogous quality modifiers (shown on th
terms relating to structures in red, to ultrastructures in blue, and to molecu
have an all-some syntax, i.e. “Tight junction has_part Occludin” means: For
instance of the type Occludin such that x has part y.(Figure 2) to be used in combination with a small set of
standardized modifiers (as ‘qualities’).
Most of the classes that are needed for the ontology of
cell parts can be found in CELDA, the ontology developed
by the CellFinder project (http://cellfinder.org/about/
ontology/) [15], that itself integrates ontologies like the
Cell Ontology (CL), the Cell Line Ontology (CLO), the
Foundational Model of Anatomy (FMA), the Gene Ontol-
ogy (GO) and Mouse Anatomy. Additional classes can be
taken from the Cellular Phenotype Ontology [16] (CPO).
For the ontology of cell mechanisms, we can re-use
(portions of ) the Interaction Network Ontology (http://
bioportal.bioontology.org/ontologies/1515) and the GO
subontology for biological processes (http://www.gene
ontology.org). The current GO (Biological Process), how-
ever, does not capture the hierarchical relationships de-
scribed in Figure 2, connecting molecular events such as
the interaction of Occludin and JAM to ultrastructural
events such as the formation of a tight junction. Here, we
need to explicitly encode the interconnections of molecu-
lar events and ultrastructural events. The ontology of cell
parts (Figure 1) is designed to handle exactly the same
challenge, on the level of the continuants. While the focus
of the CPO is on phenotype abnormalities, we can still re-
use it to provide distinct morphological and associatedell phenotypes. The figure shows a structure by which cell
m cells (ESC), can be formally represented, using entity terms (shown
e right hand side). Terms referring to cells are indicated in yellow,
les in green. With the exception of “is_a”, all relations are meant to
all instances x of the type Tight junction there is some y that is an
Figure 2 Outline of an ontology of cell mechanisms and its use to describe cell transitions. The figure shows a structure by which
mechanism changes can be formally represented, using entity terms (shown on the left hand side) and quality modifiers (shown on the right
hand side). The colour code follows the code used in Figure 3: Occurrents relevant for cell phenotypes are indicated in yellow, occurrents
relevant for ultrastructures in blue, and occurrents directly involving molecules in green. ‘Up’ and ‘down’ are intended to indicate relative
changes: ‘Interaction Occludin-JAM Up’ states that there is a development in the cell to feature more interactions of this kind, no matter how
many of them there have been before. With the exception of “is_a”, all relations are meant to have an all-some syntax (cf. Figure 1).
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Again, the hierarchical interconnections between the mo-
lecular entities and cellular parts (components, anatomical
structures, cell types) need to be explicitly established, for
example, between Occludin in tight junctions to the anat-
omy of specific cell types.
To describe cell phenotypes and transitions, we refer
to entities belonging to distinct ontological top-level cat-
egories [17]:
(1)Independent continuants: Cells and their organelles as
well as molecules are three-dimensional entities; they
are present with all their spatial parts at every time of
their existence.
(2)Dependent continuants: Any property of a cell or a
molecule, be it a quality or a disposition, also exists as a
whole at every time of its existence. However, any such
property is ontologically dependent on its particular
bearer: It cannot exist without it.
(3)Occurrents: Interactions, inhibitions, stimulations as
well as transitions are temporally extended processes.
They have temporal parts that occur at different
times; hence they do not exist as a whole at any single
point of time.We can, for example, describe the state of a cell at a
certain time by enumerating all of its parts and contents
(independent continuants), or by enumerating all of its
properties (dependent continuants), or by enumerating
all the events going on at this time (occurrents), which
could then be connected with parts and contents of the
cell as their participants, e.g. with organelles or mole-
cules. All of these categories are needed to integrate the
data available: Cellular data describe continuants (like
cellular components and dispositions) as well as occur-
rents, namely the molecular interactions (microscale
mechanisms) going on in a cell at a certain time. While
these continuants are covered by the phenotype ontol-
ogy scheme, the interactions (microscale mechanisms)
are covered by the mechanism ontology. Cell transition
data describe occurrents, namely macroscale changes of
microscale mechanisms. Within the EQ framework, we
can describe such macroscale changes of microscale
mechanisms by pairing terms for microscale mechanisms
(as ‘entities’) with specific change modifiers (as ‘qualities’).
In Figure 2 we illustrate this with one possible annotation
pattern for a cell transition. In this annotation pattern, the
entity term ‘Interaction Occludin-JAM’ from the mechan-
ism ontology is used as a subject term in combination
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time step the interaction between Occludin and JAM has
been upregulated.
In our framework, a pluripotent cell can then be char-
acterized by its expression data (about genes, proteins
etc.), from which relevant microscale mechanisms can
be inferred. A cell transition from one cell phenotype
into another (e.g., of a fibroblast into a pluripotent cell)
can be described by comparing the expression data of
both cell phenotypes, which capture macroscale changes
in microscale mechanisms. Such expression data include
the start-up of the interactions between genes/proteins
relevant for the induction of pluripotency. Such a start-up
may happen because the cell starts to produce more in-
stances of the molecule types participating in this type of
interaction. In our framework, a pluripotent cell realizes
dispositions for mechanisms relevant for pluripotency that
may be described by a network of interactions. Further, a
cell transition from fibroblast to pluripotent cell realizes
dispositions for changes in mechanisms. After transition,
the cell is characterized by the microscale mechanisms
relevant for the pluripotent phenotype.
The use of the ontologies within the EQ framework
Our ontologies are designed to be used together with
specific modifiers within the EQ framework. As shown
on the right-hand side of Figure 1, the ontology of cell
phenotypes can be used to collect annotations for cell
phenotypes such as fibroblast, epithelial cell and pluripo-
tent stem cell. We can set up annotation profiles of cells,
consisting of sets of EQ pairs that describe them. ForFigure 3 Using EQ syntax to represent cellular dynamics. The diagram
mechanism changes (MECH) work together with the EQ syntax in order to
annotation profiles for three cell types (A, B, C) and for two macroscale cha
profiles is time-stamped: A is the phenotype of the cell in question before
phenotype after 2 hours. In each annotation profile we use, e.g., terms for
represent the participants of the microscale mechanisms that are actively o
cell will normally vary through time, and such a series of profiles can be us
we use terms for mechanisms together with modifiers like ‘up’ and ‘down’
mechanism going on within the cell.example, the profile of epithelial cells includes the infor-
mation that the genes/proteins Occludin, the Junctional
adhesion molecule (JAM), Claudin as well as tight junc-
tions (TJs) are ‘present’, and cell membranes are ‘joined’.
For this purpose, we can use a number of standardized
modifiers like ‘present’, ‘absent’, ‘up’, ‘moderately up’, and
‘down’, which can be integrated within an ontology like
PATO [13]. The quality terms used in a particular annota-
tion profile are derived from the data being annotated,
describing, e.g., a specific set of epithelial cells in a specific
culture medium.
The ontology of cell mechanisms, on the other hand,
is designed to be used together with modifiers like ‘up’
and ‘down’ in order to yield descriptions for macroscale
changes of the microscale mechanisms going on within
a cell (‘up’ for start-up; ‘down’ for shutdown). The right-
hand side of Figure 2 features, e.g., the specific changes
(‘up’ for start-up) of the microscale mechanisms relevant
for TJs, which are the macroscale changes associated
with TJ formation. Within the framework of the EQ syn-
tax, qualities help to describe these changes of the mi-
croscale mechanisms. The example hierarchy in Figure 2
reflects our example of the epithelial-mesenchymal transition
(EMT) and its reversal (MET, observed during reprogram-
ming). Within an EQ-framework, an MET can be coded
using ‘network of mechanisms relevant for epithelial cell’
as the entity term and ‘up’ as the quality modifier; the ‘net-
work of mechanisms relevant for mesenchymal cell’ goes
‘down’ simultaneously. Figure 3 shows how the ontology
of phenotypes and the ontology of mechanisms can be
combined in order to represent temporal dynamics.shows how the two ontologies for cell phenotypes (PHEN) and
represent the dynamics of cellular processes. It shows fictive
nges (from type A to B, and from type B to C). Each of the cell type
a certain intervention, B the phenotype after 1 hour and C the
molecular entities together with modifiers like ‘present’ and ‘absent’ to
ngoing in a cell at a certain point of time. The phenotypic profile of a
ed to adequately describe the history of a cell in an experiment. Here,
in order to describe the macroscale changes of the microscale
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Both ontologies allow for annotation propagation. In
[12], annotations for anatomical entities are propagated
up a hierarchy of is_a and part_of relations, such that a
parent receives all the annotations of its children. The
rationale for this is the following. Every finger is part of
a hand; hence any information about a finger is also
information about some hand. Hence, whatever is expli-
citly annotated with “finger” is, implicitly, also about
some hand. Annotation propagation makes these impli-
cit annotations explicit via automated reasoning. In our
domain, however, universal part_of relations are rare: As
opposed to anatomical entities, molecules (like Occludin)
and organelles are not usually restricted to one specific
part of a cell or a specific cell, and process parts can be-
long to different process wholes. As a consequence of this,
the mereological hierarchy cannot be used in the same
way as in [12] for cell phenotypes and mechanism
changes. As there is an implicit universal quantification
over all instances of the first class in an assertion in an
ontology description language like the Web Ontology
Language (OWL) [18], we have to use has_part instead
of part_of. In our example, a molecular entity like
Occludin can belong to a range of cellular structures
and phenotypes, while a certain cellular structure or
phenotype has to possess certain molecular entities. Put
in general terms, a cellular structure necessitates its es-
sential molecular parts. That is, the whole determines
the parts, and for this reason we need to use the
has_part relation. The has_part relation is also appro-
priate for occurrents like cell mechanisms. This is be-
cause any initial temporal part of an event can happen
without the event being completed. For example, not
every S-phase needs to be part of a mitosis: the cell
cycle can be disrupted, e.g. by the destruction of the cell
that is about to divide, resulting in an S-phase that is
not followed by a cell division at all. In contrast to this,
every mitosis has an S-phase as one of its temporal
parts. Again, we need to employ the has_part hierarchy,
from whole processes to their necessary parts (e.g., from
Network_of_mechanisms_relevant_for_TJ to the Interaction_
Occludin_JAM). When employing annotation propagation,
therefore, as a rule, a whole process will have a higher in-
formation content than its necessary parts.
Similarity searches
The ontologies outlined above enable similarity searches
across cell phenotypes and mechanism changes in ana-
logy to [12]. In particular, we wish to estimate the simi-
larity of cell types and of cell transitions across time. In
this setting, macroscale changes are processes happening
from one state at a certain time to another state at a later
time. What we call microscale mechanisms are activities
around a certain time, i.e. activities that we suppose tohappen at some (maybe small) interval around that time.
Microscale mechanisms are typically described as undir-
ected activities (interactions), while macroscale changes
are of necessity directed to a certain end state. The EQ-
syntax is used to build up annotation profiles for the cell
types under scrutiny. If appropriate, they will be time-
stamped in order to mark how much time has elapsed
after a certain intervention (e.g., “two days after interven-
tion X”). If a macroscale change is the transition from cell
type A to cell type B, it can ‘inherit’ the timestamps from
the annotation profiles of A and B as its start and end
time, respectively (see also Figure 3).
Similarity searches may then compare, e.g., EMT/MET
and reprogramming data. In simplified terms, an MET
(mesenchymal-epithelial transition) [19] consists in, first,
the formation of adherens junctions (AJs) and, second,
the formation of tight junctions (TJs). We represent the
MET as the start-up of the microscale mechanisms rele-
vant for an epithelial cell, which has as one of its parts
TJ formation that is, in turn, represented as the start-up
of the mechanisms relevant for a TJ. This is the inverse of
an EMT (epithelial-mesenchymal transition, which hap-
pens in development, metastasis and fibrosis). ExprEssence
and related tools ([20-23]) can be employed for generating
annotations about mechanism changes relevant for a
certain transition by means of high-throughput data
analysis, and the more mechanisms are annotated, the
better we can estimate how similar biological processes
are. Ultimately, any set of cell transitions can be com-
pared (using data coded in EQ syntax) with respect to
the underlying mechanisms, demonstrating the power
of our approach. Our ontology design principles thus
enable a kind of BLAST search in the space of annotations
(for mechanisms), with similar goals such as highlighting
relationships (between mechanisms, based on basic
mechanisms as building blocks), and eventually estimating
their evolutionary history.
The support for similarity search that we envision is
illustrated in Figure 4. From left to right, three possible
annotation profiles are shown that could be derived from
data on MET processes. For the sake of simplicity, the
qualities considered are restricted to ‘up’ and ‘down’, mark-
ing upregulation of a mechanism (derived from high-
throughput data or literature curation) by a black tick
mark. Further assertions are then derived by automatic
annotation propagation: Our ontology of cell mechanisms
enables to infer (by subsumption reasoning, following the
idea of [12]) the magenta tick marks. Our example sug-
gests that similarity estimates after ontology-based reason-
ing are better and more reliable than without reasoning.
Clustering of cell phenotypes
While our individuation criteria for cell phenotype are
very fine-grained (even a tiny change in the molecular
Figure 4 Example of an ontology-supported similarity search. Three possible annotation profiles derived from data on MET processes are
exemplified, from left to right. Black tickmarks label mechanisms upregulated according to the data, and magenta tickmarks are inferred. After
reasoning, more plausible similarity estimates become possible.
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construct more coarse-grained cell types by clustering of
cell phenotypes based on similarity, considering the pres-
ence or absence of morphological or (ultra-)structural
components and of molecular entities. In addition, we can
also cluster the macroscale changes that transition cells
from one phenotype to another. A cluster of cells shares
aspects of components and microscale mechanisms. Gen-
erally speaking, similar phenotypes correspond to similar
cells, and similar mechanism changes correspond to simi-
lar cell transitions (cf. Figure 5). Thus, boundaries between
clusters of cells that are ‘next neighbours’ (e.g. pluripotent
embryonic stem cells and epiblast stem cells) as well as be-
tween cells on opposite ends of a developmental spectrumFigure 5 Quasi-potential landscapes and cell phenotype and
mechanism change clustering. The “quasi-potential landscape”,
adapted from [24,25], illustrates how clusters of cells (cell phenotypes)
and clusters of mechanism changes (cell transitions) are related.(e.g. mesenchymal cells and epithelial cells) can be de-
fined by clustering based on expert annotations and on
bioinformatics analyses of experimental data. Clustering
of mechanism changes (that is, of macroscale changes
in microscale mechanisms) will in turn generate clusters
of similar mechanism changes with a large distance be-
tween the clusters. The cause for this large distance
then is the existence of strongly dissimilar cells.
We suggest that the improvement in similarity estimates
afforded by our ontologies (see Figure 4) enables the
plausible clustering of both cell phenotypes and cellular
mechanisms. Then it should become possible to cluster
cell phenotype and mechanism data sufficiently well to de-
rive the clusters exemplified in Figure 5.
Conclusion
We outlined how to design ontologies that enable to (1)
formally represent cell phenotypes and mechanism changes
behind cell transitions such as (re-)programming, and to
(2) develop algorithms exploiting this framework, includ-
ing clustering and searching for similar cell phenotypes
and mechanism changes. Both ontologies support manual
curation of publication data, annotation propagation and
information content measurement, as well as the inclusion
of results from high-throughput data analysis.
Our use of EQ-syntax allows the systematic encoding
of annotation profiles of cell phenotypes and mechanism
changes. The terms for both types of entities are organized
in hierarchies ranging from molecular to (ultra)structural
to morphological entities. Annotation profiles can then be
obtained using (1) data curation from publications or by
(2) high-throughput data analysis. In ontological terms,
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an instrument for deriving mechanistic information from
high-throughput data, turning information about con-
tinuants into information about occurrents by differen-
tial analysis. The starting point for expert curation,
possibly supported by text mining, must be a set of care-
fully selected papers.
Given a rich annotated knowledge base, existing ap-
proaches for ontology-based similarity measurements [12]
can be applied to the domains of cell phenotypes and cel-
lular mechanism changes. This would yield two important
functionalities: It allows clustering of cell phenotypes (and
of mechanism changes) by similarity, providing important
information for an operational definition of cell pheno-
types, and it allows similarity search in the spaces of
mechanism changes and of cell phenotypes.
To further refine and populate the ontologies, we cur-
rently explore the option to work together with collabo-
rators in the DFG SPP 1356 (http://www.spp1356.de) on
pluripotency and cellular reprogramming, and similar
initiatives, and we are looking for further collaborations.
The size of the final artifacts is obviously a function of
time and efforts invested in their development. While
the number of relevant entities is limited for cell anat-
omy and cell types (several thousands), it is very large
and virtually unlimited for molecular entities.
To evaluate our approach, we intent to compare simi-
larity search results based on high-throughput data ana-
lysis only to results based on employing the ontologies
integrating high-throughput data, (ultra)structural data
and morphological data, and further to compare both
sets of results with the expectations of domain experts.
We expect that in particular the relationships between
molecular events (which may be derived from filtering
high-throughput data) and ultrastructural events (cu-
rated from the literature) yield improvements for simi-
larity searches (see Figure 4). To avoid a garbage-in,
garbage-out scenario, the application domain must be
strictly limited, e.g. to data describing reprogramming
and EMT experiments, so that the input data can all be
validated by domain experts. Ultimately we envision a
community-based crowd-sourcing approach.Competing interests
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